A clinical trial by Marinova has demonstrated the ability of a seaweed extract, fucoidan, to significantly ease benign prostatic hyperplasia symptoms in men aged 45-80.

An innovative clinical trial reveals that fucoidan, derived from seaweed, significantly relieves symptoms of benign prostatic hyperplasia, enhancing men's quality of life.

A pioneering clinical trial shows that Fucoidan, derived from seaweed, significantly reduces benign prostate hyperplasia symptoms in men aged 45 to 80 years.

A recent clinical trial demonstrates the efficacy of fucoidan, a natural compound from seaweed, in reducing benign prostate hyperplasia symptoms.

Fucoidan is a seaweed-derived compound used for immune support, inflammation balance, and cellular health. Learn its benefits and safe use.

The progression of chronic kidney disease (CKD) is closely associated with damage to the endothelial glycocalyx (eGC) of the renal microvasculature. The eGC, particularly its heparan sulfate (HS) components, is crucial for maintaining the charge-selective barrier and microenvironmental homeostasis. …

We present the first detailed structure of a newly discovered fucosidase that has been shown to remove terminal fucose from fucoidan, uncovering unique features that set it apart from other known fucosidases and suggesting functional diversity among its homologs.

Welcome back to Instagram. Sign in to check out what your friends, family & interests have been capturing & sharing around the world.